<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04417816</url>
  </required_header>
  <id_info>
    <org_study_id>UATC-001</org_study_id>
    <nct_id>NCT04417816</nct_id>
  </id_info>
  <brief_title>Ultrasound-induced Adipose Tissue Cavitation and Training in Obesity</brief_title>
  <acronym>UATC</acronym>
  <official_title>Ultrasound-induced Adipose Tissue Cavitation: Effects on Cardiometabolic Risk and Body Composition in Persons With Obesity</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hasselt University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hasselt University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The addition of ultrasound-induced adipose tissue cavitation (UATC) at the level of the
      abdominal subcutaneous adipose tissue may seem relevant as an additive treatment option to
      exercise intervention in individuals with obesity. However, whether individuals with obesity
      who participate in an exercise intervention and additionally undergo UATC, are more likely to
      develop a metabolically healthy phenotype, as opposed to subjects with obesity undergoing
      exercise training or UATC only, remains to be studied. Therefore, the first aim of this study
      is to examine the impact of combined UATC during exercise intervention on abdominal
      subcutaneous and whole-body adipose tissue mass, quality of life and cardiometabolic risk in
      individuals with abdominal obesity.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    At the request of the Ethical Committee
  </why_stopped>
  <start_date type="Actual">April 15, 2018</start_date>
  <completion_date type="Actual">February 28, 2020</completion_date>
  <primary_completion_date type="Actual">February 28, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Body composition</measure>
    <time_frame>baseline</time_frame>
    <description>DEXA scan (fat mass, fat free mass, android and gynoid fat mass), clinical measures (waist circumference, hip circumference, weight, height)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Body composition</measure>
    <time_frame>week 12</time_frame>
    <description>DEXA scan (fat mass, fat free mass, android and gynoid fat mass), clinical measures (waist circumference, hip circumference, weight, height)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fasting blood sample</measure>
    <time_frame>Baseline</time_frame>
    <description>(glycated haemoglobin)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Fasting blood sample</measure>
    <time_frame>week 12</time_frame>
    <description>(glycated haemoglobin)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>lipid profile</measure>
    <time_frame>Baseline</time_frame>
    <description>total LDL, HDL, triglycerides</description>
  </primary_outcome>
  <primary_outcome>
    <measure>lipid profile</measure>
    <time_frame>week 12</time_frame>
    <description>total LDL, HDL, triglycerides</description>
  </primary_outcome>
  <primary_outcome>
    <measure>kidney function</measure>
    <time_frame>Baseline</time_frame>
    <description>urea, creatinine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>kidney function</measure>
    <time_frame>week 12</time_frame>
    <description>urea, creatinine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>inflammation</measure>
    <time_frame>Baseline</time_frame>
    <description>CRP</description>
  </primary_outcome>
  <primary_outcome>
    <measure>inflammation</measure>
    <time_frame>week 12</time_frame>
    <description>CRP</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bloodpressure</measure>
    <time_frame>Baseline</time_frame>
    <description>systolic and diastolic blood pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Bloodpressure</measure>
    <time_frame>Week 12</time_frame>
    <description>systolic and diastolic blood pressure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>oral glucose tolerance test</measure>
    <time_frame>Baseline</time_frame>
    <description>glucose and insulin levels at 0, 15, 30, 45, 60, 90 and 120 min post glucose load</description>
  </primary_outcome>
  <primary_outcome>
    <measure>oral glucose tolerance test</measure>
    <time_frame>week 12</time_frame>
    <description>glucose and insulin levels at 0, 15, 30, 45, 60, 90 and 120 min post glucose load</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Overall physical fitness</measure>
    <time_frame>Baseline</time_frame>
    <description>Maximal oxygen uptake (during cardiopulmonary exercise testing)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall physical fitness</measure>
    <time_frame>week 12</time_frame>
    <description>Maximal oxygen uptake (during cardiopulmonary exercise testing)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall physical fitness</measure>
    <time_frame>Baseline</time_frame>
    <description>Maximal resistance (during cardiopulmonary exercise testing)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall physical fitness</measure>
    <time_frame>week 12</time_frame>
    <description>Maximal resistance (during cardiopulmonary exercise testing)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall physical fitness</measure>
    <time_frame>Baseline</time_frame>
    <description>Maximal heart rate (measured by electrocardiogram)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall physical fitness</measure>
    <time_frame>week 12</time_frame>
    <description>Maximal heart rate (measured by electrocardiogram)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 questionaire</measure>
    <time_frame>Baseline</time_frame>
    <description>Quality of Life questionaire, a 36-item, patient-reported survey of patient health. The SF-36 is a measure of health status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36 questionaire</measure>
    <time_frame>week 12</time_frame>
    <description>Quality of Life questionaire, a 36-item, patient-reported survey of patient health. The SF-36 is a measure of health status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Food intake</measure>
    <time_frame>Baseline</time_frame>
    <description>3-day food diary</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Food intake</measure>
    <time_frame>week 12</time_frame>
    <description>3-day food diary</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">28</enrollment>
  <condition>Obesity</condition>
  <arm_group>
    <arm_group_label>Exercise training + adipose tissue cavitation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Exercise training + sham procedure</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise training intervention with ultrasound induced adipose tissue cavitation</intervention_name>
    <description>Exercise training intervention with ultrasound induced adipose tissue cavitation</description>
    <arm_group_label>Exercise training + adipose tissue cavitation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Exercise training intervention without ultrasound induced adipose tissue cavitation</intervention_name>
    <description>Exercise training intervention with ultrasound induced adipose tissue cavitation</description>
    <arm_group_label>Exercise training + sham procedure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  male/female (1:1),

          -  age 18-65 y,

          -  abdominal obesity (waist circumference &gt;102cm or &gt;88cm) -

        Exclusion Criteria:

          -  involvement in dietary or exercise intervention in the last year,

          -  intake of any medication,

          -  clinically diagnosed diseases (cardiovascular disease, hypertension, venous thromboses
             blood diseases, presence of a pacemaker/defibrillator, brain or nervous system
             diseases, kidney, thyroid or liver disease, chronic inflammatory diseases, cancer,
             osteoporosis and epilepsy).

          -  Persons with a pregnancy,

          -  a recent bone injury or the presence of a metal prothese
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominique Hansen, prof. dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hasselt University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Kenneth Verboven, dr.</last_name>
    <role>Study Chair</role>
    <affiliation>Hasselt University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hasselt University</name>
      <address>
        <city>Diepenbeek</city>
        <zip>3590</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>May 15, 2020</study_first_submitted>
  <study_first_submitted_qc>June 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">June 5, 2020</study_first_posted>
  <last_update_submitted>June 2, 2020</last_update_submitted>
  <last_update_submitted_qc>June 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">June 5, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hasselt University</investigator_affiliation>
    <investigator_full_name>Dominique Hansen</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

